Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38.
Oxidative stress has been shown to play a crucial role in the pathophysiology of the neurodegenerative disease Ataxia Telangiectasia. We have recently demonstrated that Dexamethasone treatment is able to counteract the oxidative state by promoting nuclear factor erythroid 2-related factor 2 (NRF2) n...
Main Authors: | Sara Biagiotti, Marzia Bianchi, Luigia Rossi, Luciana Chessa, Mauro Magnani |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0216668 |
Similar Items
-
Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone.
by: Michele Menotta, et al.
Published: (2018-01-01) -
Ataxia telangiectasia
by: Letícia Sauma, et al.
Published: (2015-07-01) -
Ataxia-telangiectasia
by: Nelson Pires Ferreira
Published: (1966-09-01) -
Ataxia-Telangiectasia
by: J Gordon Millichap
Published: (1990-01-01) -
Síndrome de Ataxia-Telangiectasia Ataxia-telangiectasia: a case report
by: Amauri Batista da Silva, et al.
Published: (1971-06-01)